Rebeca Cruz Aguilar

Comparative effectiveness of vancomycin and metronidazole on event-free survival after initial infection in patients with Clostridioides difficile—a German multicentre cohort study

Katharina Giesbrecht, Rebeca Cruz Aguilar, Stefanie K. Gräfe, Klaus‐Peter Hunfeld et autres

OBJECTIVES: The objective of this study is to examine the comparative effectiveness of vancomycin and metronidazole in a confirmatory analysis of event-free survival (EFS) after initial infection in patients with Clostridioides difficile from a German multicentre cohort study. METHODS: The IBIS multicentre …

de (code pays fourni par la source)

Clostridioides difficile infections in the intensive care unit: a monocentric cohort study

Rebeca Cruz Aguilar, Jon Salmanton‐García, Jonathan Carney, Boris Böll et autres

INTRODUCTION: Patient-level data from Clostridioides difficile infections (CDI) treated in an intensive care setting is limited, despite the growing medical and financial burden of CDI. METHODS: We retrospectively analyzed data from 100 medical intensive care unit patients at the University Hospital Cologne …

de, us (code pays fourni par la source)

The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent Clostridioides difficile infections in Germany

Rosemarie Peri, Rebeca Cruz Aguilar, Kester Tüffers, Andreas Erhardt et autres

Introduction Fecal microbiota transfer (FMT) is highly effective in the treatment and prevention of recurrent Clostridioides difficile infection (rCDI) with cure rates of about 80% after a single treatment. Nevertheless, the reasons for failure in the remaining 20% remain largely elusive. The …

de (code pays fourni par la source)

Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection

Lena M. Biehl, Rebeca Cruz Aguilar, Fedja Farowski, Werner Hahn et autres

de (code pays fourni par la source)